LINC01684

Across TCGA pan-cancer cohorts, LINC01684 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC01684’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01684 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01684 is over-expressed in tumor, although a few such as UCEC and KICH show the opposite, repressed pattern.

KIRC, UCEC, and KICH are the cancer types where LINC01684 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01684 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.297	<.001	11	view →
UCEC	All	All	−0.140	<.001	6	view →
KICH	All	All	−0.037	.006	6	view →
LUSC	All	All	−0.109	<.001	5	view →
HNSC	Female	All	+0.102	.008	5	view →
STAD	All	II,III,IV	+0.085	.009	4	view →
KIRP	All	All	+0.106	.004	3	view →
COAD	Female	All	−0.038	.032	3	view →
CHOL	All	II,III,IV	−0.085	.029	2	view →
LUAD	Female	III,IV	−0.098	.047	1	view →
THCA	Male	III,IV	−0.084	.035	1	view →
BLCA	Male	IV	−0.075	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

LINC01684–KIRC

Open the KIRC breakdown →